Last kr188.80 SEK
Change Today +2.60 / 1.40%
Volume 827.8K
GETIB On Other Exchanges
Symbol
Exchange
Stockholm
Berlin
OTC US
OTC US
As of 6:10 AM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

getinge ab-b shs (GETIB) Snapshot

Open
kr186.00
Previous Close
kr186.20
Day High
kr191.90
Day Low
kr185.50
52 Week High
01/28/14 - kr237.30
52 Week Low
10/16/14 - kr147.00
Market Cap
45.0B
Average Volume 10 Days
1.5M
EPS TTM
kr7.01
Shares Outstanding
222.4M
EX-Date
03/21/14
P/E TM
26.9x
Dividend
kr4.15
Dividend Yield
2.20%
Current Stock Chart for GETINGE AB-B SHS (GETIB)

Related News

No related news articles were found.

getinge ab-b shs (GETIB) Related Businessweek News

No Related Businessweek News Found

getinge ab-b shs (GETIB) Details

Getinge AB, a medical technology company, provides medical technical equipment for surgery, intensive care, infection control, and care ergonomics in Western Europe, the United States, Canada, and internationally. The company’s Medical Systems business area offers products for surgical workplaces, cardiovascular, and critical care systems under the Maquet brand. Its product portfolio comprises surgical tables, surgical lamps, ceiling service units for medical-technical equipment, fully-equipped pre-manufactured operating rooms, equipment and instruments for cardiac surgery, vascular intervention and heart support, and ventilators and anaesthesia equipment, as well as respirators. The company’s Extended Care business area provides patient lifts, hygiene systems, hospital beds, and wound-care and pressure-ulcer prevention products, as well as diagnostics products, dopplers, and foetal monitoring equipment for elderly care and healthcare, hospitals, and home nursing under the ArjoHuntleigh brand. Its Infection Control business area offers washer and flusher disinfectors, sterilization equipment, and IT-systems and loading equipment under the Getinge and Lancer brands for the elderly, pharmaceuticals industry, and laboratories. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.

15,183 Employees
Last Reported Date: 02/25/14
Founded in 1904

getinge ab-b shs (GETIB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

getinge ab-b shs (GETIB) Key Developments

Getinge AB Announces Executive Changes

The Board of Directors of Getinge AB has decided to appoint Alex Myers as new President and CEO of the Getinge Group. Alex Myers will succeed Johan Malmquist, has informed the Board of Directors that he wants to resign from his assignment. Alex Myers will assume his new position as President and CEO of the Getinge Group in connection with the Annual General Meeting on March 25, 2015. Johan Malmquist will continue to contribute to the Group as an advisor to the Board of Directors and the new President and CEO, up until the 2016 Annual General Meeting. Alex Myers is currently President and CEO of Hilding Anders. Alex Myers has previous experience from the Getinge Group as CEO for ArjoHuntleigh and Executive Vice President for the Extended Care Business Area during 2009 to 2013.

Getinge AB(OM:GETI B) added to OMX Nordic 40 Index

Getinge AB will be added to the OMX Nordic 40 Index.

Getinge AB Announces Audited Consolidated and Parent Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Getinge AB announced audited consolidated and parent earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, on consolidated basis, the company reported net sales rose 6.4% to SEK 6,225 million against SEK 5,850 million a year ago. Profit before tax declined 11.1% to SEK 505 million against SEK 568 million a year ago. EBITA before restructuring costs increased 1.4% to SEK 920 million against SEK 907 million a year ago. Operating profit was SEK 675 million against SEK 715 million a year ago. Net profit was SEK 368 million against SEK 415 million a year ago. Net profit attributable to parent company’s shareholders was SEK 366 million against SEK 413 million a year ago. Earnings per share were SEK 1.54 against SEK 1.73 a year ago. Adjusted earnings per share were SEK 2.29 against SEK 2.33 a year ago. EBITDA was SEK 1,223 million against SEK 1,180 million a year ago. Cash flow from operations was SEK 742 million against SEK 923 million a year ago. Investments in tangible fixed assets were SEK 250 million against SEK 247 million a year ago. For the nine months, on consolidated basis, the company reported net sales rose 3.7% to SEK 18,184 million against SEK 17,530 million a year ago. Profit before tax declined 58.3% to SEK 602 million against SEK 1,445 million a year ago. Net profit declined 58.4% to SEK 439 million against SEK 1,055 million a year ago. Earnings per share declined 58.4% to SEK 1.83 against SEK 4.40 a year ago. EBITA before restructuring declined 7.7% to SEK 2,496 against SEK 2,704 million a year ago. Operating profit was SEK 1,094 million against SEK 1,890 million a year ago. Net profit attributable to parent company’s shareholders was SEK 436 million against SEK 1,049 million a year ago. Adjusted earnings per share were SEK 6.13 against SEK 6.89 a year ago. EBITDA was SEK 2,650 million against SEK 3,281 million a year ago. Cash flow from operations was SEK 2,081 million against SEK 2,134 million a year ago. Investments in tangible fixed assets were SEK 737 million against SEK 703 million a year ago. Net interest-bearing debt as on September 30, 2014 was SEK 21,360 million against SEK 18,640 million as on September 30, 2013. Return on equity was 10.1% against 13.9% a year ago. For the quarter, on parent basis, the company reported operating loss of SEK 34 million against SEK 43 million a year ago. Loss before tax was SEK 1,018 million against SEK 510 million a year ago. Net loss was SEK 1,018 million against SEK 513 million a year ago. For the nine months, on parent basis, the company reported operating loss of SEK 120 million against SEK 113 million a year ago. Loss before tax was SEK 1,519 million against profit before tax of SEK 238 million a year ago. Net loss was SEK 1,521 million against net profit of SEK 229 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GETIB:SS kr188.70 SEK +2.50

GETIB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $41.66 USD +0.26
DENTSPLY International Inc $50.75 USD -0.14
MEDNAX Inc $65.19 USD -0.34
PerkinElmer Inc $44.44 USD +0.15
Teleflex Inc $112.83 USD +1.12
View Industry Companies
 

Industry Analysis

GETIB

Industry Average

Valuation GETIB Industry Range
Price/Earnings 22.5x
Price/Sales 1.4x
Price/Book 2.3x
Price/Cash Flow 21.0x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GETINGE AB-B SHS, please visit www.getingegroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.